Clinical Trial Update: Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Romiplostim N01 to treat thrombocytopenia in patients with solid tumors receiving radiotherapy-based regimens; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors
• Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Solid Tumors | Phase 2 | Status: NOT_YET_RECRUITING